B Egestad

962 citations
19 papers · 686 indexed · h-index 14
Topics
Drug Transport and Resistance Mechanisms (9 papers)Metabolism and Genetic Disorders (5 papers)Effects and risks of endocrine disrupting chemicals (3 papers)

In The Last Decade

B Egestad

19 papers receiving 664 citations

Peers

B Egestad
Comparison fields: 5 of 80
  • Oncology 379
  • Surgery 194
  • Molecular Biology 164
  • Clinical Biochemistry 162
  • Pharmacology 114
Replace H Oftebro with:
H Oftebro Norway
Yoshikazu Emi Japan
Kyuichiro Okuda Japan
Ibrahim M. Yousef Canada
L. L. Miller United States
Inger Holmberg Sweden
Osamu Tagaya Japan
Leslie R. Schwarz Germany
Nancy M. Blankenship United States
C. G. Bly United States
B Egestad relative to H Oftebro Norway H Oftebro's profile →
Citations per field
00.5×1.5×2.2×
H Oftebro · 1×
Citations per year

Countries citing papers authored by B Egestad

Since Specialization
Citations

This map shows the geographic impact of B Egestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Egestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Egestad more than expected).

Fields of papers citing papers by B Egestad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Egestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Egestad. The network helps show where B Egestad may publish in the future.

Co-authorship network of co-authors of B Egestad

This figure shows the co-authorship network connecting the top 25 collaborators of B Egestad. A scholar is included among the top collaborators of B Egestad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Egestad. B Egestad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 15
2 9
3 82
4 60
5 6
6 67
7
Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients.
17
8 47
9 32
10 20
11 2
12
Familial giant cell hepatitis associated with synthesis of 3β,7α-dihydroxy- and 3β,7α,12α-trihydroxy-5-cholenoic acid
40
13 35
14 135
15 37
16 43
17 18
18 8
19 13

About B Egestad

B Egestad is a scholar working on Clinical Biochemistry, Pharmacology and Oncology, having authored 19 papers that have together received 686 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Metabolism and Genetic Disorders (5 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). The work is most often cited by research in Clinical Biochemistry (162 citations), Oncology (379 citations) and Pharmacology (114 citations). B Egestad has collaborated with scholars based in Sweden, United States and Slovakia. Frequent co-authors include Jan Sjövall, Hanns–Ulrich Marschall, H. Matern, S Matern, Peter T. Clayton, Stig Andersson, A. M. Lawson, J V Leonard, Kenneth D.R. Setchell and H. Wietholtz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026